Patent details

Basic Information

Publication number:

EP3509626

PCT Application Number:

EP2017072591

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177677846

PCT Publication Number:

WO2018046666

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FIBRONECTIN OR ILK INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA

French Title of Invention:

FIBRONECTINE À UTILISER DANS LE TRAITEMENT DE LA LEUCÉMIE

German Title of Invention:

FIBRONECTIN ZUR VERWENDUNG BEI DER BEHANDLUNG VON LEUKÄMIE

SPC Number:

Dates

Filing date:

08/09/2017

Grant date:

13/10/2021

EP Publication Date:

17/07/2019

PCT Publication Date:

15/03/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/10/2021

EP B1 Publication Date:

13/10/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/09/2022

Expiration date:

08/09/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/10/2021

 

 

Name:

Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus

Address:

Paul-Ehrlich-Strasse 42-44, 60596 Frankfurt, Germany (DE)

Inventor

1

Name:

MEISTER, Melanie

Address:

Germany (DE)

2

Name:

KRAUSE, Daniela

Address:

Germany (DE)

3

Name:

KUMAR, Rahul

Address:

Germany (DE)

Priority

Priority Number:

16187926

Priority Date:

08/09/2016

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C07K 14/78; C07K 14/82; A61K 38/39; A61K 38/00; A61K 39/395; C12N 9/12; A61K 31/506; A61K 45/06;

Publication

European Patent Bulletin

Issue number:

202141

Publication date:

13/10/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages